10x Genomics, Inc. (FRA:1KJ)

10x Genomics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,226	1,679	5,985	3,903	14,632	12,456
Market Cap Growth	29.79%	-71.94%	53.34%	-73.33%	17.46%	90.63%
Enterprise Value	1,886	1,377	5,751	3,570	14,174	11,878
Last Close Price	16.36	13.46	51.72	33.91	127.05	115.15
PS Ratio	4.07	2.85	10.69	8.08	33.92	50.99
PB Ratio	3.33	2.45	8.93	5.18	20.35	20.62
P/TBV Ratio	3.65	2.52	9.19	5.36	21.13	21.26
P/OCF Ratio	29.50	260.86	-	-	-	-
EV/Sales Ratio	3.42	2.34	10.27	7.39	32.86	48.62
Debt / Equity Ratio	0.11	0.12	0.13	0.12	0.10	0.09
Asset Turnover	0.65	0.65	0.62	0.50	0.50	0.39
Inventory Turnover	2.56	2.50	2.70	1.70	1.65	2.59
Quick Ratio	3.93	4.09	3.96	4.08	6.10	6.05
Current Ratio	4.48	4.97	4.69	4.85	6.77	6.56
Return on Equity (ROE)	-10.12%	-25.17%	-32.98%	-20.45%	-7.48%	-93.64%
Return on Assets (ROA)	-8.42%	-12.77%	-12.52%	-9.99%	-3.40%	-6.95%
Return on Capital (ROIC)	-9.84%	-14.77%	-14.37%	-11.37%	-3.89%	-8.52%
Return on Capital Employed (ROCE)	-15.00%	-24.00%	-23.80%	-18.20%	-5.80%	-10.50%
Earnings Yield	-2.92%	-10.51%	-3.86%	-3.98%	-0.35%	-3.56%
FCF Yield	3.13%	-0.33%	-0.96%	-3.96%	-0.74%	-1.67%
Buyback Yield / Dilution	-3.07%	-2.80%	-2.90%	-3.18%	-9.09%	-158.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.